Compliance with the regulations | Audit
With the introduction of the Medicines for Human Use (Clinical Trials) Regulations 2004, it is necessary to audit Trust and QMUL research practice against the quality system of Good Clinical Practice intrinsic to the Regulations and encompassed in the Research Governance Framework. As Sponsor the Trust and Queen Mary University of London (QMUL) are responsible for auditing research practice and adherence to current legislation and guidelines.
This page contains guidance to assist researchers in understanding the processes of audit, so that they are prepared should they be selected for internal audit.
The purpose of internal audit of research is to:
The Research Governance Framework requires that all NHS Organisations, where research is being conducted, will initiate formal audit of a selection of research projects and activities. The minimum standard in the Framework states that at least 10% of projects should be routinely audited.
A project should be audited:
A written report on study progression does not constitute audit and should be submitted for every study in addition to audit requirements.
It is the auditor’s primary role to collect evidence of research practice and compare it against the requirements of Good Clinical Practice and Research Governance. The auditor is responsible for documenting observations and conclusions, safeguarding audit documents, records and reports, assessing whether requirements are being met, and developing reports incorporating recommendations for change or adherence.
A number of processes are required to compile a complete sample of available data. These are:
An audit plan should be developed by the auditor and agreed by the Joint Research Department prior to the audit beginning.
The plan should:
An open meeting will be arranged to introduce the auditor to the team and area to be audited.
During this meeting the auditor will:
This is the most intensive part of any audit process as it is the period where information is assessed and recorded.
This will be done by:
Once the review and observational components have been completed the auditor processes the data to define conclusions and preliminary recommendations.
The auditor will:
The auditor will arrange a closing meeting to discuss the compiled evidence, observations, conclusions, recommendations or nonconformities. This is an interim measure to suggest an outcome but should not be viewed as the final and complete results of the audit.
Over the following 2 weeks from initial audit, the auditor will review the gathered information and compile a final report, which will be disseminated to Senior Research and Development staff, the Medical Director and the Chief/Principal Investigator.
The report will include:
It is the auditor’s responsibility to identify necessary action has been carried out to correct and prevent nonconformities. This will be in the form of a re-audit of the identified nonconformities and will occur no later than 6 months after the final report is issued. In this way the Trust can ensure appropriate corrective action has been taken.
Find more information on how to prepare for audit in our leaflet below.
Download Preparing for audit leaflet.
Alternatively, for more information about the audit process, please contact the GCP team.